Commission Regulation (EC) No 1356/2004 of 26 July 2004 concerning the authorisation for 10 years of the additive «Elancoban» in feedingstuffs, belonging to the group of coccidiostats and other medicinal substances(Text with EEA relevance)

• CELEX: Regulation (EC) No 1356/2004
• Articles: 5

Article 1

Chapter I of Annex B to Directive 70/524/EEC is amended as follows:

The additive monensin sodium, belonging to the group ‘Coccidiostats and other medical substances’, shall be deleted.

Article 2

The additive Elancoban belonging to the group ‘Coccidiostats and other medical substances’, as set out in the Annex to the present Regulation is authorised for use in animal nutrition under the conditions laid down in that Annex.

Article 3

A period of six months from the date of entry into force of this Regulation is permitted to use up the existing stocks of monensin sodium.

Article 4

This Regulation shall enter into force on the third day following that of its publication in the Official Journal of the European Union .

Schedules & Appendices

ANNEX

ANNEX

Registration number of additive

Name and registration number of person responsible for putting the additive into circulation

Additive

(trade name)

Composition, chemical formula, description

Species or category of animal

Maximum age

Minimum content

Maximum content

Other provisions

Period of authorisation

mg of active substance/kg of complete feedingstuff

Coccidiostats and other medicinal substances

‘E 757

Eli Lilly and Company Limited

Monensin sodium

Active substance:

C 36 H 61 O 11 Na

sodium salt of polyether monocarboxylic acid produced by Streptomyces cinnamonensis , ATCC 15413 in granular form.

Factor composition:

Monensin A: not less than 90 %

Monensin: A + B: not less than 95 %

Chickens for fattening

—

100

125

Use prohibited at least three days before slaughter.

Indicate in the instructions for use: Dangerous for equines. This feedingstuff contains an ionophore: avoid simultaneous administration with tiamulin and monitor for possible adverse reactions when used concurrently with other medicinal substances.

30.7.2014’

Elancoban G100

Elancoban 100

Elancogran 100

Additive composition:

Granular monensin (dried fermentation product) equivalent to Monensin activity 10 % w/w

Mineral oil 1-3 % w/w

Limestone granular 13-23 % w/w

Rice hulls or limestone granular qs 100 % w/w

Chickens reared for laying

16 weeks

100

120

Indicate in the instructions for use: Dangerous for equines. This feedingstuff contains an ionophore: avoid simultaneous administration with tiamulin and monitor for possible adverse reactions when used concurrently with other medicinal substances.

Elancoban G200

Elancoban 200

Granular monensin (dried fermentation product) equivalent to Monensin activity 20 % w/w

Mineral oil 1-3 % w/w

Rice hulls or limestone granular qs 100 % w/w

Turkeys

16 weeks

60

100

Use prohibited at least three days before slaughter.

Indicate in the instructions for use: Dangerous for equines. This feedingstuff contains an ionophore: avoid simultaneous administration with tiamulin and monitor for possible adverse reactions when used concurrently with other medicinal substances.